Dextromethorphan and guaifenesin use ought to be monitored cautiously in individuals with "lousy metabolizer" CYP2D6 enzyme degrees and sufferers who're sedated. This combination medication contains a massive median toxic dose (TD50) to median productive dose (ED50) ratio (or therapeutic index) in these sufferers. Keep at space temperature faraway from light https://peakbookmarks.com/story18268778/the-definitive-guide-to-dextromethorphan-dxm-for-sale-in-europe